Back to Search
Start Over
PMS20 COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN BIOLOGIC-EXPERIENCED PATIENTS FROM THE PORTUGUESE PERSPECTIVE
- Source :
- Value in Health. 22:S697
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
- Subjects :
- Ankylosing spondylitis
medicine.medical_specialty
business.industry
Health Policy
Perspective (graphical)
Public Health, Environmental and Occupational Health
Cost-effectiveness analysis
medicine.disease
language.human_language
language
medicine
Physical therapy
Secukinumab
Portuguese
business
Subjects
Details
- ISSN :
- 10983015
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi...........182283764da1763210f1cf03f7573999